This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

"As a cancer patient, having options to manage the side effects of life saving drugs is very important. I believe the published results of crofelemer for the prophylaxis of CTD are very exciting and ...

Pembrolizumab and XL888 in advanced CRC showed manageable safety, though limited responses and potential immunomodulatory ...

The statistically significant responder analysis results for Mytesi® (crofelemer) in the OnTarget study's prespecified subgroup of patients with breast cancer were the subject of a December 2024 poste ...

Kisumu health department said the three died earlier this week. Poor hygiene has been suspected to be the cause of the ...

The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht), expanding treatment options for ...

Psyllium husk is a powder that's rich in fiber, which is known to increase satiety and reduce appetite. Because it can ...